ArticleJournal of medical case reports2026
Long-term organophosphate exposure leading to delayed neuropathy in a pesticide applicator: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOrganophosphate-induced delayed neuropathy (OPIDN) is a rare, serious neurological consequence of organophosphate poisoning. Unlike acute toxicity, which causes cholinergic crises, OPIDN develops insidiously, often weeks after exposure, leading to progressive sensorimotor deficits. CASE PRESENTATION: A 44-year-old African male pesticide applicator with nine years of organophosphate exposure presented with progressive lower limb weakness, gait disturbances, and paresthesia. The patient exhibited no signs of acute cholinergic symptoms. Neurological examination revealed symmetrical limb weakness, diminished deep tendon reflexes, and distal sensory deficits. Serum cholinesterase levels were decreased. Electrophysiological studies demonstrated axonal degeneration with demyelination, and MRI showed mild spinal cord atrophy. Other causes of neuropathy were excluded. He received supportive care, including physical therapy, pain and spasticity management, antioxidants, vitamins, and off-label intravenous methylprednisolone. Over four months, he regained partial functional improvement, with residual weakness and mild gait disturbance.
conclusionsChronic low-level organophosphate exposure can cause OPIDN even without acute poisoning. Diagnosis relies on occupational history, neurological examination, and electrophysiological findings. Management is primarily supportive; off-label therapies such as methylprednisolone may reduce neuroinflammation and oxidative stress but are not part of standard care. Early recognition, timely preventive measures, and long-term rehabilitation are essential to improve functional outcomes and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.